Amundi’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$50.5M Sell
558,514
-207,560
-27% -$19M 0.01% 592
2025
Q4
$68.9M Buy
766,074
+49,227
+7% +$4.67M 0.02% 568
2025
Q3
$70.8M Buy
716,847
+80,190
+13% +$7.95M 0.02% 482
2025
Q2
$59.5M Sell
636,657
-401,103
-39% -$38.8M 0.02% 523
2025
Q1
$117M Sell
1,037,760
-117,066
-10% -$12.5M 0.04% 368
2024
Q4
$117M Sell
1,154,826
-71,482
-6% -$7.67M 0.04% 391
2024
Q3
$125M Sell
1,226,308
-83,831
-6% -$9.15M 0.05% 349
2024
Q2
$140M Sell
1,310,139
-89,330
-6% -$10.5M 0.05% 304
2024
Q1
$167M Sell
1,399,469
-26,165
-2% -$3.27M 0.07% 273
2023
Q4
$174M Sell
1,425,634
-190,762
-12% -$21.3M 0.08% 273
2023
Q3
$169M Buy
1,616,396
+48,849
+3% +$6.2M 0.08% 261
2023
Q2
$223M Buy
1,567,547
+709,384
+83% +$96.4M 0.11% 206
2023
Q1
$110M Buy
858,163
+52,716
+7% +$6.62M 0.06% 335
2022
Q4
$100M Buy
805,447
+107,135
+15% +$12.4M 0.05% 346
2022
Q3
$78.5M Sell
698,312
-61,701
-8% -$6.77M 0.05% 399
2022
Q2
$77.3M Buy
760,013
+148,350
+24% +$17.6M 0.06% 322
2022
Q1
$79.5M Sell
611,663
-1,274,925
-68% -$154M 0.05% 352
2021
Q4
$235M Sell
1,886,588
-792,312
-30% -$104M 0.15% 169
2021
Q3
$381M Sell
2,678,900
-64,123
-2% -$9.43M 0.27% 81
2021
Q2
$428M Buy
+2,743,023
New +$444M 0.3% 70

Other funds holding ZBH

Amundi's ZBH Position: Q1 2026 in Review

Amundi reduced its Zimmer Biomet (ZBH) stake by 27% in Q1 2026, selling an estimated $19M and leaving 558,514 shares worth $50.5M. The position accounts for 0.01% of the portfolio, ranked #592.

Amundi first reported a position in ZBH in Q2 2021 and has held it in 20 quarters since. The position peaked at $428M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Amundi held 558,514 shares of Zimmer Biomet worth $50.5M as of Q1 2026.
  • Amundi sold 207,560 Zimmer Biomet shares in Q1 2026, an estimated $19M.
  • Zimmer Biomet made up 0.01% of Amundi's portfolio in Q1 2026, its #592 holding.
  • Amundi first reported a position in Zimmer Biomet in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Zimmer Biomet position peaked at $428M in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.